Clinical Trial

Primary Sclerosing Cholangitis in Children

Recruiting
View on ClinicalTrials.gov →
Summary
Primary sclerosing cholangitis (PSC) is a rare liver disease that damages the liver's bile ducts. Bile ducts are tiny tubes that carry bile from the liver to the small intestine. Bile is a liquid produced by the liver that helps us absorb and use the nutrients in the food we eat. In people with PSC, the bile backs up into the liver and will damage it, causing scarring of the liver. The purposes of this study are to: * Collect medical and other data to learn more about PSC, how it progresses, and identify factors that may cause the disease to progress more quickly. * Ask questions about how PSC symptoms affect your child's life to learn more about its impact on your child's daily functioning * Children with PSC who are seen at one of the participating clinical sites in the Childhood Liver Disease Research Network (ChiLDReN) will be asked to contribute information, DNA, and other specimens. The information and specimens will be available to investigators to carry out approved research aimed at learning more about the possible causes and long-term effects of PSC.
Protocol Amendment History 17 amendments
This ClinicalTrials.gov record has been amended 17 times since 2019-11-26; most recent amendment 2026-07-13.
Status change: Not Yet Recruiting → Recruiting 2022-03-09
Trial Details
NCT Number NCT04181138
Lead Sponsor Arbor Research Collaborative for Health
Collaborators: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions Primary Sclerosing Cholangitis, Liver Diseases, Cholangitis, Sclerosing
Enrollment 1,000 participants
Start Date 2021-12-30
Primary Completion 2029-05-31 (estimated)
Study Completion 2029-05-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-14